quinazolines has been researched along with Koch's Disease in 8 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 5 (62.50) | 24.3611 |
| 2020's | 3 (37.50) | 2.80 |
| Authors | Studies |
|---|---|
| Dahal, A; El-Sadek, M; Emam, AM; Enriz, RD; Ibrahim, SM; Jois, SD; Kothayer, H; Singh, SS; Tosso, RD | 1 |
| Chakraborti, AK; Dhameliya, TM; Jadhavar, PS; Krishna, VS; Patel, KI; Saha, N; Sriram, D; Vaja, MD | 1 |
| Dutta, A; Sarma, D | 1 |
| Alam, S; Gupta, A; Maurya, HK; Negi, AS; Pandey, S; Pathak, V; Sharma, S; Srivastava, KK; Verma, R | 1 |
| Devi, PB; Jeankumar, VU; Pedgaonkar, GS; Renuka, J; Saxena, S; Sridevi, JP; Sriram, D; Yogeeswari, P | 1 |
| Bhakta, S; Bucar, F; Evangelopoulos, D; Guzman, JD; Hochfellner, C; Kunert, O; McHugh, TD; Wube, A; Zloh, M | 1 |
| Anbarasu, A; Jha, DK; Lavanya, P; Panda, L; Ramaiah, S | 1 |
| Cho, SN; Franzblau, SG; Hwang, JM; Kaneko, T; Kim, P; Ma, Z; Oh, T; Upton, AM | 1 |
1 review(s) available for quinazolines and Koch's Disease
| Article | Year |
|---|---|
Recent advances in the synthesis of Quinazoline analogues as Anti-TB agents.
Topics: Animals; Antitubercular Agents; Drug Design; Drug Resistance, Bacterial; Humans; Molecular Structure; Mycobacterium tuberculosis; Quinazolines; Structure-Activity Relationship; Tuberculosis | 2020 |
7 other study(ies) available for quinazolines and Koch's Disease
| Article | Year |
|---|---|
Quinazoline-tethered hydrazone: A versatile scaffold toward dual anti-TB and EGFR inhibition activities in NSCLC.
Topics: A549 Cells; Antineoplastic Agents; Antitubercular Agents; Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; ErbB Receptors; Erlotinib Hydrochloride; Fibroblasts; Humans; Hydrazones; Lung Neoplasms; Models, Molecular; Mycobacterium tuberculosis; Quinazolines; Structure-Activity Relationship; Tuberculosis | 2021 |
Benzimidazoquinazolines as new potent anti-TB chemotypes: Design, synthesis, and biological evaluation.
Topics: Animals; Antitubercular Agents; Benzimidazoles; Cell Survival; Dose-Response Relationship, Drug; Drug Design; Mice; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Quinazolines; RAW 264.7 Cells; Structure-Activity Relationship; Tuberculosis | 2020 |
Studies on substituted benzo[h]quinazolines, benzo[g]indazoles, pyrazoles, 2,6-diarylpyridines as anti-tubercular agents.
Topics: Antitubercular Agents; Cell Line; Humans; Indazoles; Mycobacterium tuberculosis; Pyrazoles; Pyridines; Quinazolines; Tuberculosis | 2013 |
Development of 2-(4-oxoquinazolin-3(4H)-yl)acetamide derivatives as novel enoyl-acyl carrier protein reductase (InhA) inhibitors for the treatment of tuberculosis.
Topics: Acetamides; Animals; Bacterial Proteins; Cell Line; Cell Survival; Dose-Response Relationship, Drug; Enzyme Inhibitors; Mice; Microbial Sensitivity Tests; Molecular Docking Simulation; Molecular Structure; Mycobacterium tuberculosis; Oxidoreductases; Quinazolines; Structure-Activity Relationship; Tuberculosis | 2014 |
Antagonistic effects of indoloquinazoline alkaloids on antimycobacterial activity of evocarpine.
Topics: Alkaloids; Anti-Bacterial Agents; Drug Antagonism; Humans; Mycobacterium tuberculosis; Plant Extracts; Quinazolines; Quinolones; Tuberculosis | 2015 |
Detection and confirmation of alkaloids in leaves of Justicia adhatoda and bioinformatics approach to elicit its anti-tuberculosis activity.
Topics: 3-Oxoacyl-(Acyl-Carrier-Protein) Synthase; Alkaloids; Antitubercular Agents; Computational Biology; Fatty Acid Synthase, Type II; Humans; Justicia; Molecular Docking Simulation; Mycobacterium tuberculosis; Plant Leaves; Pyrroles; Quinazolines; Tuberculosis | 2012 |
Design, synthesis, and structure-activity relationship studies of tryptanthrins as antitubercular agents.
Topics: Animals; Antitubercular Agents; Cytochrome P-450 Enzyme System; Drug Design; Humans; Mice; Mice, Inbred C57BL; Microbial Sensitivity Tests; Molecular Structure; Mycobacterium tuberculosis; Quinazolines; Rats; Structure-Activity Relationship; Tuberculosis | 2013 |